Global Brachytherapy Therapy Market 2018-2024 - ResearchAndMarkets.com

DUBLIN--()--The "Global Brachytherapy Therapy Market 2018-2024" report has been added to ResearchAndMarkets.com's offering.

The Global Brachytherapy Device Market is estimated to witness a CAGR of 6.06% during the forecast period 2018-2024

APAC is the most focused and has substantial growth due to vast opportunities for vendors to establish their presence. Factors such as growing public awareness, increase in aging population, growing assisted living facilities, presence of large potential customer base, and increased initiatives by government support will boost the market growth. The region is witnessing a rapid growth in the healthcare industry as well.

The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure and the governments have taken initiatives to develop the healthcare facilities in both urban and rural areas. The increased demand for better services among patients and the increased life expectancy in this region are factors that will boost the overall healthcare facility in the region. Also, countries in this region have a strong focus towards the development of healthcare that will include coverage for patients aged 65 and above.

Brachytherapy devices market is expected to increase rapidly. HDR segment has the maximum share in the global brachytherapy devices market. Developments in imaging technology coupled with advancements in computer technology, have revolutionized the processes for tumor targeting and radiation therapy planning. Technologies used in internal beam radiation therapy include high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, intermediate dose rate, and pulsed dose rate; and products include seeds, applicators, after loaders, and accessories.

Based on applications, the market is segmented into prostate cancer, cervical cancer, gallbladder, uterus, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Based on end-users, the market is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others.

The market enjoys the participation of many global, regional, and local players who are competing fiercely to gain a strong foothold as top vendor. Big players, such Elekta AB, Varian Medical Systems, and C.R. Bard (now BD) often acquire small yet promising companies to increase their market share. Most giant companies are using acquisition strategies to expand their business operations by leveraging their products portfoli--across the globe.

The main products in the Brachytherapy market include:

  • Oncentra Brachy Treatment Planning System by Elekta
  • Brachytherapy Afterloaders and Applicators by Varian Medical Systems
  • SOURCELINK Delivery System by C.R. Bard (now BD)
  • FASTFILL Brachytherapy Needle by C.R. Bard (now BD)
  • IsoSeed, IsoStrand, and LDR Needles by Eckert & Ziegler BEBIG
  • TheraStrand - Strand and AnchorLoad - needle by Theragenics

Key Stakeholders:

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Brachytherapy Market Segmentation By Methods: Market Size & Analysis

5 Brachytherapy Market Segmentation By Consumables

6 Brachytherapy Market Segmentation By Applications

7 End-Users: Market Size And Analysis

8 Regions: Market Size & Analysis

9 Competitive Landscape

10 Vendor Profiles

  • Elekta AB
  • Varian Medical Systems Inc.
  • C. R. Bard Inc.
  • Eckert & Ziegler Bebig
  • Theragenics Corp

11 Companies To Watch For

  • Carl Zeiss Meditec AG
  • Mevion Medical Systems Inc.
  • Nordion Inc.
  • Isoray Inc.
  • Hitachi Medical Corp.

For more information about this report visit https://www.researchandmarkets.com/research/cd74hk/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology